Brief: Biosynex: Successful Takeover Bid Initiated For Theradiag Shares

Theradiag SA

16/01/2023 17:19

Jan 16 (Reuters) - Biosynex SA  ALBIO.PA :
    * SUCCESSFUL TAKEOVER BID INITIATED BY BIOSYNEX FOR
THERADIAG
SHARES
    * REOPENING OF THE OFFER FOR A MINIMUM OF 10 DAYS OF
NEGOTIATION
    * BASED ON A SHARE CAPITAL OF 13,118,227 SHARES REPRESENTING
A
MAXIMUM OF 13,174,282 VOTING RIGHTS, BIOSYNEX WILL HOLD
9,032,820 SHARES REPRESENTING THE SAME NUMBER OF VOTING RIGHTS,
I.E. 68.86% OF THE SHARE CAPITAL AND AT LEAST 68.56% OF THE
VOTING RIGHTS, AT THE SETTLEMENT-DELIVERY DATE OF JANUARY 31,
2023
    * AMF WILL PUBLISH A CALENDAR FOR THE REOPENING OF THE OFFER
AT A
LATER TIME, WILL ENABLE SHAREHOLDERS WHO HAVE NOT YET TENDED
SHARES TO DO SO AT PRICE 2.30 EUR PER THERADIAG SHARE

Source text for Eikon:  ID:nEQbGw9LRa 
Further company coverage:  ALBIO.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))